Translate Bio, Inc. Common Stock
TBIO
TBIO was delisted on the 13th of September, 2021.
146 hedge funds and large institutions have $1.1B invested in Translate Bio, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 62 increasing their positions, 42 reducing their positions, and 28 closing their positions.
48% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 42
3% less funds holding
Funds holding: 150 → 146 (-4)
7% less capital invested
Capital invested by funds: $1.18B → $1.1B (-$84.7M)
11% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 28
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
64% less call options, than puts
Call options by funds: $5.01M | Put options by funds: $13.8M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
+$32M |
| 2 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$26.2M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$21.9M |
| 4 |
Goldman Sachs
New York
|
+$13.9M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$13.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$34.6M |
| 2 |
AVA
Atlas Venture Advisors
Boston,
Massachusetts
|
-$17.9M |
| 3 |
BCPEMI
Bain Capital Public Equity Management II
Boston,
Massachusetts
|
-$8.88M |
| 4 |
AG
Artal Group
Luxembourg
|
-$4.56M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$4.5M |
TBIO Hedge Fund Activity: Q1 2021 in Review
146 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Translate Bio, Inc. Common Stock (TBIO) for Q1 2021, worth a combined $1.1B — down 7.1% from $1.18B a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of TBIO and 25 opened new positions — a net loss of 3 holders — while 42 trimmed existing stakes and 62 added.
The largest buyer was RTW Investments, adding an estimated $32M. The largest seller was Fidelity Investments, cutting an estimated $34.6M.
- 146 institutional investors held Translate Bio, Inc. Common Stock (TBIO) as of Q1 2021, down from 150 in Q4 2020.
- Funds reported $1.1B of Translate Bio, Inc. Common Stock stock for Q1 2021, down 7.1% quarter-over-quarter.
- 25 funds opened new Translate Bio, Inc. Common Stock positions in Q1 2021 and 28 closed out, a net change of -3 holders.
- The largest Translate Bio, Inc. Common Stock buyer in Q1 2021 was RTW Investments, an estimated $32M added.
- The largest Translate Bio, Inc. Common Stock seller in Q1 2021 was Fidelity Investments, an estimated $34.6M sold.
Based on aggregated 13F filings for Q1 2021.